CAMBRIDGE, England & NOTTINGHAM, England–(BUSINESS WIRE)–Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced the data from a successful Phase I…
Author: Business Wire
NVISION Eye Centers' Subsidiary, NVISION Clinical Research, Rapidly Expands Under New Leadership
ALISO VIEJO, Calif.–(BUSINESS WIRE)–NVISION Eye Centers, a renowned national leader in comprehensive eye care services, proudly announces the remarkable expansion of its subsidiary, NVISION Clinical Research, LLC. Spearheaded by the visionary leaders…
Amring Pharmaceuticals Inc. Announces Name Change to Nordic Pharma, Inc. Under New Nordic Group, B.V. Ownership
BERWYN, Pa.–(BUSINESS WIRE)–Amring Pharmaceuticals Inc. announces name change to Nordic Pharma, Inc. under new Nordic Group, B.V. ownership on March 4, 2024.
LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced financial results for the quart…
GenSight Biologics Announces LUMEVOQ® Scientific Updates at NANOS 2024
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central …
GenSight Biologics annonce des communications scientifiques sur LUMEVOQ® au Congrès 2024 du NANOS
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniques innovantes pour les maladies neurod…
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted seven newly-hired non-executive employees stock options to purchas…
Stephen Carrier joins Health Network One as Network President
FT. LAUDERDALE, Fla.–(BUSINESS WIRE)–Stephen Carrier joins Health Network One as Network President
Celanese Announces Commercial Launch of Glaukos' iDose® TR (Travoprost Intracameral Implant) Using Celanese's VitalDose® Ethylene Vinyl Acetate (EVA)
DALLAS–(BUSINESS WIRE)—- $CE–Celanese Announces Commercial Launch of Glaukos’ iDose® TR (Travoprost Intracameral Implant) using Celanese’s VitalDose® Ethylene Vinyl Acetate (EVA)
Bausch + Lomb Announces Appointment of Karen L. Ling to Board of Directors
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Karen L. Ling has been appointed to its Board of Directors (t…
Warby Parker Announces Fourth Quarter and Full Year 2023 Results
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (“Warby Parker” or the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the fourth quarter and full year ended December 31, 2023….
Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023
GENEVA–(BUSINESS WIRE)–Alcon’s Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023
Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023
GENEVA–(BUSINESS WIRE)–Alcon’s Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023
Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today reported recent business highlights and fi…
Yonge Street Mission (YSM) Unveils The Richard and Lorelei Jenkins & Family Health and Dental Centre at YSM’s Evergreen Centre for Street-Involved Youth
TORONTO–(BUSINESS WIRE)–Yonge Street Mission Unveils The Richard and Lorelei Jenkins & Family Health and Dental Centre at YSM’s Evergreen Centre for Street-Involved Youth
National Vision Holdings, Inc. Reports Fourth Quarter and Fiscal 2023 Financial Results
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today reported its financial results for the fourth quarter and fiscal year ended December 30, 2023, and is providing its outlook for fiscal…
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today reported financial re…
Samenvatting: Via haar dochteronderneming Amring Pharmaceuticals Inc. benoemt Nordic Group B.V. de oftalmologie-innovator Eric D. Donnenfeld, MD tot voorzitter van de Medische Adviesraad
BERWYN, Pa.–(BUSINESS WIRE)–Amring Pharmaceuticals Inc. (Amring), een dochternonderneming van Nordic Group B.V. (Nordic Pharma), maakte vandaag bekend dat de vooraanstaande oftalmoloog Eric D. Donnenfeld, MD de Amerikaanse Medische Adviesraad (U.S. M…
Resumen: Nordic Group B.V. a través de su filial Amring Pharmaceuticals Inc. nombra presidente del consejo asesor médico al Dr. Eric D. Donnenfeld, innovador en oftalmología
BERWYN, Pensilvania–(BUSINESS WIRE)–Amring Pharmaceuticals Inc. (Amring), filial de Nordic Group B.V. (Nordic Pharma), ha anunciado hoy que el eminente Dr. en oftalmología Eric D. Donnenfeld presidirá su Junta de asesoramiento médico (MAB) en EE.UU.,…
Nordic Group B.V., par l’intermédiaire de sa filiale Amring Pharmaceuticals Inc., nomme le Dr Eric D. Donnenfeld, innovateur en ophtalmologie, au poste de président de son conseil consultatif médical
BERWYN, Pennsylvanie–(BUSINESS WIRE)–Amring Pharmaceuticals Inc. (Amring), une filiale de Nordic Group B.V. (Nordic Pharma), a annoncé aujourd’hui que l’éminent ophtalmologiste, le Dr Eric D. Donnenfeld, présidera désormais son Conseil consultatif mé…